Sweden
Fourth State Systems is a pioneering company focused on revolutionizing healthcare through the development of cutting-edge technology for transcutaneous blood gas monitoring. The company's slogan, "Developing new technology for transcutaneous blood gas monitoring," captures their commitment to innovation and advancing patient care. Founded in 2018 and based in Sweden, Fourth State Systems is at the forefront of the biotechnology and healthcare industries.
The significance of their work in enabling the measurement of carbon dioxide and oxygen levels through the skin is crucial for modern healthcare, particularly in the realm of neonatal care. By providing non-invasive monitoring solutions, Fourth State Systems has the potential to revolutionize current practices and significantly enhance patient outcomes.
While specific details about their last investment and investors are not available at this time, the potential of Fourth State Systems in shaping the future of transcutaneous blood gas monitoring makes it a compelling prospect for venture capital. As the company continues to drive innovation and make strides in this critical area of healthcare, it presents a compelling opportunity for investment and collaboration.
